Skip to main content
Erschienen in: World Journal of Surgery 12/2019

03.09.2019 | Original Scientific Report

Impact of Preoperative Skeletal Muscle Quality Measurement on Long-Term Survival After Curative Gastrectomy for Locally Advanced Gastric Cancer

verfasst von: Yuhei Waki, Tomoyuki Irino, Rie Makuuchi, Akifumi Notsu, Satoshi Kamiya, Yutaka Tanizawa, Etsuro Bando, Taiichi Kawamura, Masanori Terashima

Erschienen in: World Journal of Surgery | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Skeletal muscle quality is a prognostic factor in various cancers. However, similar studies on curatively resected gastric cancer are lacking. We evaluated skeletal muscle quality using intramuscular adipose tissue content (IMAC) to clarify its impact on survival in patients with locally advanced gastric cancer.

Methods

We reviewed 370 patients who underwent curative resection for stage II/III gastric cancer. IMAC was calculated using preoperative computed tomography images. IMAC cutoff values were determined for each sex and were set at the 75th percentile. The patients were classified into normal and high IMAC groups according to the cutoff values. Clinicopathological factors and survival outcomes were compared between the two groups. Multivariate Cox regression analysis was used to identify independent prognostic factors for overall survival (OS) and cancer-specific survival (CSS).

Results

In all, 277 patients were classified into the normal IMAC group and 93 were classified into the high IMAC group. The patients in the high IMAC group were older, more obese, and had more comorbidities and poor Eastern Cooperative Oncology Group performance status than those in the normal IMAC group. Although no significant differences were observed in the pathological findings between the two groups, a high IMAC was significantly associated with poor OS and CSS. Multivariate analysis identified high IMAC as an independent prognostic factor for both OS and CSS (p = 0.046 and p = 0.035, respectively).

Conclusions

High IMAC was significantly associated with poor survival, suggesting that skeletal muscle quality has oncological implications in patients with locally advanced gastric cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Papenfuss WA, Kukar M, Oxenberg J et al (2014) Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 21:3008–3014CrossRef Papenfuss WA, Kukar M, Oxenberg J et al (2014) Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 21:3008–3014CrossRef
2.
Zurück zum Zitat Zhuang CL, Huang DD, Pang WY et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95:e3164CrossRef Zhuang CL, Huang DD, Pang WY et al (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95:e3164CrossRef
3.
Zurück zum Zitat Kawamura T, Makuuchi R, Tokunaga M et al (2018) Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann Surg Oncol 25:1625–1632CrossRef Kawamura T, Makuuchi R, Tokunaga M et al (2018) Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann Surg Oncol 25:1625–1632CrossRef
4.
Zurück zum Zitat Huang DD, Chen XX, Chen XY et al (2016) Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study. J Cancer Res Clin Oncol 142:2347–2356CrossRef Huang DD, Chen XX, Chen XY et al (2016) Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study. J Cancer Res Clin Oncol 142:2347–2356CrossRef
5.
Zurück zum Zitat Aoyama T, Sato T, Segami K et al (2016) Risk factors for the loss of lean body mass after gastrectomy for gastric cancer. Ann Surg Oncol 23:1963–1970CrossRef Aoyama T, Sato T, Segami K et al (2016) Risk factors for the loss of lean body mass after gastrectomy for gastric cancer. Ann Surg Oncol 23:1963–1970CrossRef
6.
Zurück zum Zitat Sakurai K, Kubo N, Tamura T et al (2017) Adverse effects of low preoperative skeletal muscle mass in patients undergoing gastrectomy for gastric cancer. Ann Surg Oncol 24:2712–2719CrossRef Sakurai K, Kubo N, Tamura T et al (2017) Adverse effects of low preoperative skeletal muscle mass in patients undergoing gastrectomy for gastric cancer. Ann Surg Oncol 24:2712–2719CrossRef
7.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRef
8.
Zurück zum Zitat Marcus RL, Addison O, Kidde JP et al (2010) Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging 14:362–366CrossRef Marcus RL, Addison O, Kidde JP et al (2010) Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging 14:362–366CrossRef
9.
Zurück zum Zitat Goodpaster BH, Carlson CL, Visser M et al (1985) (2001) Attenuation of skeletal muscle and strength in the elderly: The health ABC study. J Appl Physiol 90:2157–2165CrossRef Goodpaster BH, Carlson CL, Visser M et al (1985) (2001) Attenuation of skeletal muscle and strength in the elderly: The health ABC study. J Appl Physiol 90:2157–2165CrossRef
10.
Zurück zum Zitat Ryall JG, Schertzer JD, Lynch GS (2008) Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9:213–228CrossRef Ryall JG, Schertzer JD, Lynch GS (2008) Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9:213–228CrossRef
11.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S et al (2015) Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 22:475–485CrossRef Hamaguchi Y, Kaido T, Okumura S et al (2015) Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 22:475–485CrossRef
12.
Zurück zum Zitat Okumura S, Kaido T, Hamaguchi Y et al (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088–1098CrossRef Okumura S, Kaido T, Hamaguchi Y et al (2015) Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 157:1088–1098CrossRef
13.
Zurück zum Zitat Okumura S, Kaido T, Hamaguchi Y et al (2016) Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 159:821–833CrossRef Okumura S, Kaido T, Hamaguchi Y et al (2016) Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery 159:821–833CrossRef
14.
Zurück zum Zitat Joglekar S, Asghar A, Mott SL et al (2015) Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol 111:771–775CrossRef Joglekar S, Asghar A, Mott SL et al (2015) Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol 111:771–775CrossRef
15.
Zurück zum Zitat Buettner S, Wagner D, Kim Y et al (2016) Inclusion of sarcopenia outperforms the modified frailty index in predicting 1-year mortality among 1326 patients undergoing gastrointestinal surgery for a malignant indication. J Am Coll Surg 222:397–407.e2CrossRef Buettner S, Wagner D, Kim Y et al (2016) Inclusion of sarcopenia outperforms the modified frailty index in predicting 1-year mortality among 1326 patients undergoing gastrointestinal surgery for a malignant indication. J Am Coll Surg 222:397–407.e2CrossRef
16.
Zurück zum Zitat Wagner D, Buttner S, Kim Y et al (2016) Clinical and morphometric parameters of frailty for prediction of mortality following hepatopancreaticobiliary surgery in the elderly. Br J Surg 103:e83–92CrossRef Wagner D, Buttner S, Kim Y et al (2016) Clinical and morphometric parameters of frailty for prediction of mortality following hepatopancreaticobiliary surgery in the elderly. Br J Surg 103:e83–92CrossRef
17.
Zurück zum Zitat Lu J, Zheng ZF, Li P et al (2018) A novel preoperative skeletal muscle measure as a predictor of postoperative complications, long-term survival and tumor recurrence for patients with gastric cancer after radical gastrectomy. Ann Surg Oncol 25:439–448CrossRef Lu J, Zheng ZF, Li P et al (2018) A novel preoperative skeletal muscle measure as a predictor of postoperative complications, long-term survival and tumor recurrence for patients with gastric cancer after radical gastrectomy. Ann Surg Oncol 25:439–448CrossRef
18.
Zurück zum Zitat Kitajima Y, Eguchi Y, Ishibashi E et al (2010) Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol 45:218–224CrossRef Kitajima Y, Eguchi Y, Ishibashi E et al (2010) Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol 45:218–224CrossRef
19.
Zurück zum Zitat Kitajima Y, Hyogo H, Sumida Y et al (2013) Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. J Gastroenterol Hepatol 28:1507–1514CrossRef Kitajima Y, Hyogo H, Sumida Y et al (2013) Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. J Gastroenterol Hepatol 28:1507–1514CrossRef
20.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S et al (2014) Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 20:1413–1419CrossRef Hamaguchi Y, Kaido T, Okumura S et al (2014) Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 20:1413–1419CrossRef
21.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S et al (2017) Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation 101:565–574CrossRef Hamaguchi Y, Kaido T, Okumura S et al (2017) Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation 101:565–574CrossRef
22.
Zurück zum Zitat Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123CrossRef Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123CrossRef
23.
Zurück zum Zitat Nishikawa H, Shiraki M, Hiramatsu A et al (2016) Japan society of hepatology guidelines for sarcopenia in liver disease (1st Edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 46:951–963CrossRef Nishikawa H, Shiraki M, Hiramatsu A et al (2016) Japan society of hepatology guidelines for sarcopenia in liver disease (1st Edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res 46:951–963CrossRef
25.
Zurück zum Zitat Zoico E, Corzato F, Bambace C et al (2013) Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance. Arch Gerontol Geriatr 57:411–416CrossRef Zoico E, Corzato F, Bambace C et al (2013) Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance. Arch Gerontol Geriatr 57:411–416CrossRef
26.
Zurück zum Zitat Park J, Morley TS, Kim M et al (2014) Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 10:455–465CrossRef Park J, Morley TS, Kim M et al (2014) Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 10:455–465CrossRef
27.
Zurück zum Zitat Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457–465CrossRef Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457–465CrossRef
28.
Zurück zum Zitat Dalamaga M (2013) Interplay of adipokines and myokines in cancer pathophysiology: emerging therapeutic implications. World J Exp Med 3:26–33CrossRef Dalamaga M (2013) Interplay of adipokines and myokines in cancer pathophysiology: emerging therapeutic implications. World J Exp Med 3:26–33CrossRef
29.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S et al (2016) Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition 32:1200–1205CrossRef Hamaguchi Y, Kaido T, Okumura S et al (2016) Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition 32:1200–1205CrossRef
30.
Zurück zum Zitat Chen LK, Liu LK, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101CrossRef Chen LK, Liu LK, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101CrossRef
31.
Zurück zum Zitat Carnevale V, Castriotta V, Piscitelli PA et al (2018) Assessment of skeletal muscle mass in older people: comparison between 2 anthropometry-based methods and dual-energy X-ray absorptiometry. J Am Med Dir Assoc 19:793–796CrossRef Carnevale V, Castriotta V, Piscitelli PA et al (2018) Assessment of skeletal muscle mass in older people: comparison between 2 anthropometry-based methods and dual-energy X-ray absorptiometry. J Am Med Dir Assoc 19:793–796CrossRef
32.
Zurück zum Zitat Maddocks M, Murton AJ, Wilcock A (2011) Improving muscle mass and function in cachexia: non-drug approaches. Curr Opin Support Palliat Care 4:361–364CrossRef Maddocks M, Murton AJ, Wilcock A (2011) Improving muscle mass and function in cachexia: non-drug approaches. Curr Opin Support Palliat Care 4:361–364CrossRef
33.
Zurück zum Zitat Argiles JM, Busquets S, Lopez-Soriano FJ et al (2012) Are there any benefits of exercise training in cancer cachexia? J Cachexia Sarcopenia Muscle 2:73–76CrossRef Argiles JM, Busquets S, Lopez-Soriano FJ et al (2012) Are there any benefits of exercise training in cancer cachexia? J Cachexia Sarcopenia Muscle 2:73–76CrossRef
34.
Zurück zum Zitat Di Girolamo FG, Situlin R, Mazzucco S et al (2014) Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care 2:145–150CrossRef Di Girolamo FG, Situlin R, Mazzucco S et al (2014) Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia. Curr Opin Clin Nutr Metab Care 2:145–150CrossRef
35.
Zurück zum Zitat Dallmann R, Weyermann P, Anklin C et al (2011) The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia. J Cachexia Sarcopenia Muscle 3:163–174CrossRef Dallmann R, Weyermann P, Anklin C et al (2011) The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia. J Cachexia Sarcopenia Muscle 3:163–174CrossRef
36.
Zurück zum Zitat Grossmann M (2014) Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia? J Clin Endocrinol Metab 10:3625–3628CrossRef Grossmann M (2014) Myostatin inhibition: a new treatment for androgen deprivation-induced sarcopenia? J Clin Endocrinol Metab 10:3625–3628CrossRef
Metadaten
Titel
Impact of Preoperative Skeletal Muscle Quality Measurement on Long-Term Survival After Curative Gastrectomy for Locally Advanced Gastric Cancer
verfasst von
Yuhei Waki
Tomoyuki Irino
Rie Makuuchi
Akifumi Notsu
Satoshi Kamiya
Yutaka Tanizawa
Etsuro Bando
Taiichi Kawamura
Masanori Terashima
Publikationsdatum
03.09.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 12/2019
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05145-1

Weitere Artikel der Ausgabe 12/2019

World Journal of Surgery 12/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.